A Randomised Open-label, Multicenter, Phase 2 Study Comparing the Effects on Proliferation and the Efficacy and Tolerability of Fulvestrant (FASOLDEX) 500mg with Fulvestrant 250mg when given as Neoadjuvant Treatment in Postmenopausal.......

  • Rea, Daniel (Principal Investigator)

Project Details

Short titleA Randomised Open-label, Multicenter, Phase 2 Study Comparing the Effects on Proliferation and the Efficacy and Tolerability of Fulvestrant (FASOLDEX) 500mg with Fulvestrant 250mg when given as Neoadjuvant Treatment in Postmenopausal.......
StatusFinished
Effective start/end date1/07/06 → 30/06/07

Funding

  • Queen Elizabeth Hospital Birmingham